China Resources Pharmaceutical Group Limited (3320.HK)
HKD 4.97
(-0.4%)
HKD 4.97
(-0.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 271.69 Billion HKD | 12.6% |
| 2022 | 241.28 Billion HKD | -2.93% |
| 2021 | 248.56 Billion HKD | 18.72% |
| 2020 | 209.37 Billion HKD | 10.18% |
| 2019 | 190.02 Billion HKD | 7.86% |
| 2018 | 176.18 Billion HKD | 9.6% |
| 2017 | 160.75 Billion HKD | 19.98% |
| 2016 | 133.98 Billion HKD | 5.38% |
| 2015 | 127.14 Billion HKD | 4.39% |
| 2014 | 121.79 Billion HKD | 16.19% |
| 2013 | 104.82 Billion HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 286.2 Billion HKD | 0.0% |
| 2023 FY | 271.69 Billion HKD | 12.6% |
| 2023 Q4 | 246.77 Billion HKD | 0.0% |
| 2023 Q2 | 272.74 Billion HKD | 0.0% |
| 2022 FY | 241.28 Billion HKD | -2.93% |
| 2022 Q2 | 256.25 Billion HKD | 0.0% |
| 2022 Q4 | 241.28 Billion HKD | 0.0% |
| 2021 Q4 | 248.56 Billion HKD | 0.0% |
| 2021 Q2 | 234 Billion HKD | 0.0% |
| 2021 FY | 248.56 Billion HKD | 18.72% |
| 2020 Q4 | 209.37 Billion HKD | 0.0% |
| 2020 Q2 | 197.16 Billion HKD | 0.0% |
| 2020 FY | 209.37 Billion HKD | 10.18% |
| 2019 Q4 | 190.02 Billion HKD | 0.0% |
| 2019 FY | 190.02 Billion HKD | 7.86% |
| 2019 Q2 | 199.1 Billion HKD | 0.0% |
| 2018 FY | 176.18 Billion HKD | 9.6% |
| 2018 Q4 | 176.18 Billion HKD | 0.0% |
| 2018 Q2 | 168.53 Billion HKD | 0.0% |
| 2017 Q4 | 160.75 Billion HKD | 0.0% |
| 2017 FY | 160.75 Billion HKD | 19.98% |
| 2017 Q2 | 151.64 Billion HKD | 0.0% |
| 2016 Q2 | 125.91 Billion HKD | 0.0% |
| 2016 Q4 | 133.98 Billion HKD | 0.0% |
| 2016 FY | 133.98 Billion HKD | 5.38% |
| 2015 FY | 127.14 Billion HKD | 4.39% |
| 2015 Q4 | 127.14 Billion HKD | 0.0% |
| 2014 FY | 121.79 Billion HKD | 16.19% |
| 2013 FY | 104.82 Billion HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -29840.043% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | -1106.713% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -21007.655% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -12868.074% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -56726.135% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -9299.056% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -9508.834% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -15629.167% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -32092.811% |
| SSY Group Limited | 11.96 Billion HKD | -2170.498% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -19464.773% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -7691.993% |